On 2025-05-06, Day One Biopharmaceuticals, Inc. (DAWN) announced earnings per share of $-0.35 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-0.46.
The next expected annoucement date for quarterly earnings is 2025-07-29, with an average estimated earnings per share of $-0.35 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-06 | 2025-03-31 | $-0.46 | $-0.35 |
| 2025-02-25 | 2024-12-31 | $-0.35 | $-0.69 |
| 2024-10-30 | 2024-09-30 | $-0.20 | $0.38 |
| 2024-07-30 | 2024-06-30 | $-0.67 | $-0.05 |
| 2024-05-06 | 2024-03-31 | $-0.67 | $-0.72 |
| 2024-02-26 | 2023-12-31 | $-0.57 | $-0.64 |
| 2023-11-06 | 2023-09-30 | $-0.60 | $-0.54 |
| 2023-08-07 | 2023-06-30 | $-0.60 | $-0.61 |
| 2023-05-01 | 2023-03-31 | $-0.60 | $-0.59 |
| 2023-03-06 | 2022-12-31 | $-0.57 | $-0.56 |
| 2022-11-07 | 2022-09-30 | $-0.53 | $-0.53 |
| 2022-08-04 | 2022-06-30 | $-0.49 | $-0.60 |
| 2022-05-12 | 2022-03-31 | $-0.39 | $-0.48 |
| 2021-11-08 | 2021-09-30 | $-0.28 | $-0.33 |
| 2021-08-10 | 2021-06-30 | $-0.33 | $-0.63 |